AIMEDBIO
Seoul
About AIMEDBIO
AIMEDBIO provides therapeutic solutions to patients with serious brain diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $66.3M
- Funding stage: IPO
- Last round: Series Unknown (Jun 2025)
- Ticker: kosdaq:0009K0
- Website: aimedbio.com
- Phone: +82 2 6285 0743
Industries & Categories
Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/aimedbio-7693 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.